Lipomedics Inc.

City of Industry, CA · Founded 2014 · Biotech · Private

Lipid nanoparticle drug delivery system for pharmaceutical formulations

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · lipomedics.com

Sector: Biotech
Headquarters: City of Industry, CA
Founded: 2014
Latest Form D: $1M, Jun 2016
Total capital: $1.8M

Federal grants: $441K; 2 awards · 2016; Rank in peer group#340 of 392
Private capital raised: $1.3M; 2 Form D · last Jun 2016; 125 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Jun 2016Private capital raisedForm D · SEC · 2nd filing$1M
Jun 2016Private capital raisedForm D · SEC · 1st filing$342K
Mar 2016Federal grantHealth and Human S · Phase I · Targeting the plasma high density lipoprotein (SR-B1) receptor for effective anti-cancer therapeutics.$221K
Feb 2016Federal grantHealth and Human S · Phase I · Targeting the plasma high density lipoprotein (SR-B1) receptor for effective anti-cancer therapeutics.$221K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

4months

from Lipomedics Inc.’s first federal award to its first private round.

First federal award · Feb 2016: Health and Human S · $221K
First Form D · Jun 2016: $342K · 1st Form D
Awards before first raise: 2 awards

An association in public records, not a cause or a prediction.

Standing among 392 peers

Line = median

Biotech · Molecule

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

De TapasExecutive OfficerNamed in SEC Form D filings
Tapas DeExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

GEMNEO BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts
TriAltus Bioscience, LLCSimilar federal contract value in Biotech · null in contracts
PHARMAIN CORPORATIONSimilar federal contract value in Biotech · null in contracts
METANOIA BIO LLCSimilar federal contract value in Biotech · null in contracts
LOXAGEN INC.Similar federal contract value in Biotech · null in contracts
PSYCHOGENICS, INC.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.